Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: WE PHARMA, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2025-09-16 to 2026-09-16
Current total value of award: $300000
Description: PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.